Patents & Intellectual Properties From Dr. Muhammed Majeed
Patents & Intellectual Properties
Innovation recognized by the world
Sl. No. | Title | Patent No | Brand /Ingredient |
1 | Microbial bioconversion of curcuminoids to Calebin-A | US 11,299,706 | Curcousin™ |
2 | Isolates from spent turmeric for the management of rheumatoid arthritis | US 11,298,395 | Starmeric® |
3 | Modulation of immune function by Bacillus coagulans | US 11,298,381 | Immunospore™ |
4 | Hypolipidemic effects of Bacillus coagulans | US 11,213,553 | LactoSpore® |
5 | Stable probiotic composition for the management of lactose intolerance | US 11,202,810 | LactoSpore® |
6 | Fructophilic lactic acid producing bacteria | US 11,197,898 | Fructospore® |
7 | Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans |
US 11,123,382 | LactoSporin® |
8 | Beverage compositions containing Bacillus coagulans MTCC 5856 | US 11,052,125 | LactoSpore® |
9 | Compositions for weight loss | US 11,052,125 | Cyperus + Forskolin + Garcinol |
10 | Composition for the therapeutic management of hypomelanotic skin conditions | US 11,045,517 | Forskolin + Nigellin® |
11 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 |
US 10,966,919 | LactoSporin® |
12 | Bioactive molecules from Oroxylum indicum and their therapeutic applications | US 10,959,980 | Sabroxy® |
13 | Compositions containing thymohydroquinone and their method of preparation | US 10,945,969 | Nigellin® |
14 | Method of inhibiting propionibacterium acnes | US 10,898,536 | Artocarpus |
15 | Neuroprotective compositions and their use | US 10,894,029 | Sabroxy® |
16 | Compositions for the management of hyperglycemia and related conditions | US 10,881,623 | Nigellin® |
17 | Composition for prostaglandin transporter inhibition and related therapeutic applications | US 10,864,243 | Sabeet® + Nigellin® + Arjuna + SelenoForce® |
18 | Aphrodisiac composition and management of male sexual dysfunction | US 10,864,242 | Xxtrastrong |
19 | Skin care compositions and their applications | US 10,864,154 | Ethyl ascorbic acid + THC |
20 | Compositions and methods for reducing flatulence | US 10,806,760 | LactoSpore® |
21 | Composition for management of Helicobacter pylori infection | US 10,792,295 | LactoSpore® + Saberry® |
22 | Adaptogenic compositions and applications thereof | US 10,716,823 | Polybos + Saberry® Polybos + Cococin™ |
23 | Stable probiotic composition containing Bacillus coagulans MTCC 5856 and method of detection thereof |
US 10,668,115 | LactoSpore® |
24 | Liver protectant compositions and therapeutic applications | US 10,653,643 | LivLonga® |
25 | Beverage compositions containing Bacillus coagulans MTCC 5856 | US 10,609,935 | LactoSpore® |
26 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof |
US 10,588,844 | Oletrip |
27 | Composition containing Oroxylin A and method of extraction thereof | US 10,555,982 | Oroxylin |
28 | Telomerase enhancement potential of Ecdysterone | US 10,548,902 | Ecdysterone |
29 | Functional nutritional blend for thermo-metabolic performance | US 10,477,886 | Metabolicgard |
30 | Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna |
US 10,479,749 | Arjunoglucoside |
31 | Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts | US 10,421,734 | 3-Amino Tetrahydrofurans |
32 | Process for synthesis of Oroxylin A | US 10,407,401 | Sabroxy® |
33 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
US 10,323,227 | LactoSpore® + Starmeric™ |
34 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
US 10,293,008 | LactoSpore® |
35 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 |
US 10,260,112 | LactoSpore® |
36 | Functional nutritional blend for thermo-metabolic performance | US 10,258,073 | Metabolicgard |
37 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 10,172,903 | Cyperus |
38 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | US 10,166,261 | LactoSpore® |
39 | Process and compositions for achieving mammalian energy balance | US 10,085,963 | Forskolin |
40 | Oleanoyl peptide composition and skin hydration | US 10,071,043 | Olepent® |
41 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene | US 9,913,809 | Zingiber cassumnar |
42 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene | US 9,833,422 | Zingiber cassumnar |
43 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9,782,450 | Cyperus |
44 | Calebin A for hepatic steatosis | US 9,737,502 | Calebin |
45 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
US 9,717,766 | LactoSpore® + LactoCran™ |
46 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,681,666 | LactoSporin® + SabiLize® |
47 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,681,665 | LactoSporin® |
48 | Method for the treatment of hypercholesterolemia | US 9,668,999 | Calebin |
49 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,635,862 | LactoSporin®, LactoSporin® + Sabilize® |
50 | Method for the treatment of hypercholesterolemia | US 9,610,273 | Calebin |
51 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,596,861 | LactoSporin® |
52 | Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans |
US 9,579,352 | LactoSpore® |
53 | Calebin A for osteoporosis | US 9,539,232 | Calebin |
54 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | US 9,498,423 | Saberry® + Cococin™ + Se Peptide |
55 | Process for the manufacture of 3′-hydroxy pterostilbene | US 9,458,075 | 3-hydroxypterostilbene |
56 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9,387,193 | Cyperus |
57 | Synthesis of Calebin A and its biologically active analogs | US 9,365,486 | Calebin |
58 | Anti-obesity potential of Calebin A | US 9,328,330 | Calebin |
59 | Composition and method for the protection of articular cartilage | US 9,220,703 | Calebin |
60 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,056,074 | 3-hydroxypterostilbene |
61 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,050,284 | 3-hydroxypterostilbene |
62 | Synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 9,029,547 | Pharmaceutical Intermediates |
63 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,029,424 | 3-hydroxypterostilbene |
64 | Oleanoyl peptide composition and method of treating skin aging | US 8,987,212 | Olepent® |
65 | Anti-obesity potential of Calebin A | US 8,933,121 | Calebin |
66 | Novel synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 8,853,407 | Pharmaceutical intermediates |
67 | Inotilone derivatives as coherent biological response modifier (cBMR) | US 8,394,852 | Inotilone derivatives |
68 | Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals |
US 8,383,594 | Olepent® |
69 | Compositions and its use in treating obesity or inducing weight loss | US 8,329,743 | Livinol™+ Pterostilbene + Anthocyanin |
70 | Preservative system for cosmetic formulations—compositions and methods thereof | US 8,329,095 | SabiLize® |
71 | Protective compositions for dermal papilla cells | US 8,247,003 | Saberry® + Cococin™ |
72 | Dipeptides incorporating selenoamino acids with enhanced bioavailability–synthesis, pharmaceutical and cosmeceutical applications thereof |
US 8,193,156 | LSM-Dipeptide Synthetic route |
73 | Treatment of superficial and cutaneous mycoses with a pure form of 1,7-bis(4-hydroxy-3-methoxyphe nyl)-3,5-heptanedione |
US 8,119,696 | Tetrapure® |
74 | Dipeptides incorporating selenoaminoacids with enhanced bioavailability-synthesis | US 8,003,614 | MSC-Dipeptide Synthetic route |
75 | Hydro-alkoxyl citronellal compounds – synthetic routes, compositions and uses thereof | US 7,842,842 | Woody Odorants |
76 | Composition and methods for the management of hyperproliferative dermatological conditions | US 7,582,314 | Boswellin® |
77 | Novel non-cytotoxic synthetic analogues of (1E, 6E )-1,7-Bis (4 hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic fibrosis |
US 7,521,580 | Curcuminoid analogs |
78 | Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans, their salts and derivatives |
US 7,514,573 | 3-Aminotetrahydrofurans |
79 | Convenient process of manufacture for Difluoromethylornithine and related compounds | US 7,345,196 | Efflornithine |
80 | Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance |
US 7,300,682 | Cococin™ |
81 | Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers |
US 7,253,324 | Stilbenes |
82 | Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails |
US 7,217,546 | Policosanol |
83 | Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: Process for their manufacture and Uses |
US 7,202,270 | Liposol® |
84 | Bioavailable composition of natural and synthetic HCA | US 7,063,861 | GarCitrin® |
85 | Compositions and methods containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation |
US 7,014,874 | SelenoForce® |
86 | Convenient process of manufacture for Difluoromethylornithine and related compounds | US 6,998,502 | Efflornithine |
87 | Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use |
US 6,982,273 | Methyselene® (MSC) |
88 | Process for preparing water soluble diterpenes and their applications | US 6,960,300 | Ocufors® |
89 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
US 6,849,645 | Cosmoperine® (THP) |
90 | Manufacturing processes for Se-methyl-selenocysteine | US 6,794,537 | Methyselene® (MSC) |
91 | Process of obtaining compositions of stable lutein and lutein derivatives | US 6,689,400 | ZeaLutein® |
92 | Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii | US 6,607,712 | Coleus Oil |
93 | Composition and method containing products extracted from commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease | US 6,436,991 | Gugulipid® |
94 | New Chemical entities with multiple modes of anti-inflammatory action | US 7,378,442 | AKBBA+NSAIDS |
95 | New chemical entities with multiple modes of anti-inflammatory action | US 7,371,889 | AKBBA+NSAIDS |
96 | Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels | US 7,160,562 | Metformin-like compounds |
97 | Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid | US 6,770,782 | Citrin® K |
98 | Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays | US 6,653,327 | Tetrahydrocurcuminoids |
99 | Process for making high purity piperine for nutritional use | US 6,054,585 | BioPerine® |
100 | Use of piperine as a bioavailability enhancer | US 5,972,382 | BioPerine® |
101 | Bioprotectant composition, method of use and extraction process of curcuminoids | US 5,861,415 | Curcumin C3 Complex® |
102 | Method of preparing a forskolin composition from forskolin extract and use of forskolin for promoting lean body mass and treating mood disorders | US 5,804,596 | ForsLean® |
103 | Potassium hydroxycitrate for the suppression of appetite and induction of weight loss | US 5,783,603 | Citrin® K |
104 | Use of piperine as a bioavailability enhancer | US 5,744,161 | BioPerine® |
105 | Use of piperine to increase bioavailability of nutritional compounds | US 5,536,506 | BioPerine® |
Sl. No. | Title | Patent No | Brand /Ingredient |
1 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Australia AU2006235807 |
Curcumin C3 Reduct® |
2 | Compositions containing thymohydroquinone and their method of preparation | Australia AU2018397667 |
Nigellin® |
3 | Alcoholic beverage composition containing Bacillus coagulans | Australia AU2018337853 |
LactoSpore® |
4 | Compositions and methods for reducing flatulence | Australia AU2018282018 |
LactoSpore® |
5 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Australia AU2018282252 |
LactoSporin® |
6 | Enzyme composition for therapeutic management of muscle soreness | Australia AU2016428484 |
DigeZyme® |
7 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Australia AU2016413572 |
LactoSpore® |
8 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2015394033 |
Cyperus |
9 | Oleanoyl peptide compositions and collagen enhancement | Australia AU2015381703 |
Olepent® |
10 | Bioavailable composition of natural and synthetic HCA | Australia AU773081 |
GarCitrin® |
11 | Compositions and methods for the management of hyperproliferative dermatological conditions | Australia AU2004322710 |
Boswellin® |
12 | Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Australia AU2006321973 |
SelenoForce® |
13 | Process for preparing water soluble diterpenes and their applications | Australia AU2004272005 |
Ocufors® |
14 | Anti-obesity potential of Calebin A | Australia AU2012366253 |
Calebin |
15 | Hepatoprotectant activity of garcinol | Australia AU2011352073 |
Livinol™ |
16 | Composition for down-regulating pro-inflammatory markers | Australia AU2011200854 |
Boswellin® PS |
17 | Protective compositions for dermal papilla cells | Australia AU2010326651 |
Saberry® + Cococin™ |
18 | Oleanoyl peptide composition and a method of treating skin aging | Australia AU2011265587 |
Olepent® |
19 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2014369819 |
LactoSporin® |
20 | Method for the treatment of hypercholesterolemia | Australia AU2014202312 |
Calebin |
21 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Australia AU2012203148 |
Saberry® + Cococin™+ Se Peptide |
22 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Australia AU2015308650 |
LactoSpore® |
23 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2013292593 |
Cyperus |
24 | Composition and method for the protection of articular cartilage | Australia AU2014201769 |
Calebin |
25 | Anti-obesity potential of Calebin A | Australia AU2014203122 |
Calebin |
26 | Process and compositions for achieving mammalian energy balance | Australia AU2015351423 |
Forskolin |
27 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl) butadiene | Australia AU2016385393 |
Zingiber cassumnar |
28 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Australia AU2018335280 |
LactoSporin® |
29 | Synthesis of Calebin A and its biologically active analogs | Australia AU2014203764 |
Calebin |
30 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2017228561 |
LactoSporin® |
31 | Use of piperine as a bioavailability enhancer | Canada CA2247467 |
BioPerine® |
32 | Forskolin for promoting lean body mass | Canada CA2281562 |
ForsLean® |
33 | Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Canada CA3047702 |
Artocarpus hirsutus |
34 | Composition containing Oroxylin A and method of extraction thereof | Canada CA3043168 |
Sabroxy® |
35 | Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Canada CA3047701 |
Artocarpus hirsutus |
36 | Bacillus coagulans MTCC 5856 For The Management Of Major Depressive Disorder | Canada CA3023818 |
LactoSpore® |
37 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Canada CA2999517 |
LactoSpore® |
38 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Canada CA2883176 |
Cyperus |
39 | Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins | Canada CA2537820 |
Ocufors® |
40 | Anti-obesity Potential of Calebin A | Canada CA2857543 |
Calebin |
41 | Composition for down-regulating pro-inflammatory markers | Canada CA2732915 |
Boswellin® PS |
42 | Hepatoprotectant activity of garcinol | Canada CA2851663 |
Livinol™ |
43 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Canada CA2872535 |
Saberry® + Cococin™+ Se Peptide |
44 | Method for the treatment of hypercholesterolemia | Canada CA2850999 |
Calebin |
45 | Synthesis of Calebin A and its biologically active analogs | Canada CA2858126 |
Calebin |
46 | Calebin A for hepatic steatosis | Canada CA2893321 |
Calebin |
47 | Composition and method for the protection of articular cartilage | Canada CA2935898 |
Calebin |
48 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Canada CA2899511 |
LactoSporin®, LactoSporin® + Sabilize® |
49 | Method for the treatment of hypercholesterolemia | Canada CA2963383 |
Calebin |
50 | Calebin A for osteoporosis | Canada CA2941050 |
Calebin |
51 | Oleanoyl peptide composition and collagen enhancement | Canada CA2975170 |
Olepent® |
52 | Method to solubilize curcuminoids in water | Canada CA2976689 |
uC3 CLEAR® |
53 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Canada CA2979287 |
Zingiber cassumnar |
54 | Method for the treatment of hypercholesterolemia | Taiwan I622384 |
Calebin |
55 | Composition for down-regulating pro-inflammatory markers | Taiwan I-434696 |
Boswellin® PS |
56 | Method of solubilising forskolin and isoforskolin in water and clear aqueous solution comprising the same | Vietnam 12717 |
Ocufors® |
57 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Germany DE10196213 |
Cosmoperine® |
58 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Hong kong HK1240122 |
LactoSpore® |
59 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Hong kong HK1232483 |
Cyperus |
60 | Process and compositions for achieving mammalian energy balance | Hong kong HK1238675 |
Forskolin |
61 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Hong kong HK1233174 |
LactoSpore® |
62 | Synthesis of Calebin A and its biologically active analogs | Hong kong HK1217689 |
Calebin |
63 | Process for preparing water soluble diterpenes and their applications | Hong kong HK1098450 |
Ocufors® |
64 | Method for the treatment of hypercholesterolemia | Hong kong HK1210590 |
Calebin |
65 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Hong kong HK1193758 |
Saberry®+ Cococin™ + Se Peptide |
66 | Calebin A for articular cartilage | Hong kong HK1210028 |
Calebin |
67 | Calebin A for use in the treatment of Inflammation and obesity | Hong kong HK1190874 |
Calebin |
68 | Process and compositions for achieving mammalian energy balance | China ZL201580083933.4 |
Forskolin |
69 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | China ZL201680008035.7 |
LactoSpore® |
70 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | China ZL201580042813.X |
LactoSpore® |
71 | Process For Preparing Water Soluble Diterpenes And Their Applications | China ZL200480028804.7 |
Ocufors® |
72 | Compositions and methods for the management of hyperproliferative dermatological conditions | China ZL200480043675.9 |
Boswellin® |
73 | Anti-obesity potential of Calebin A | China ZL201280012577.3 |
Calebin |
74 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | China ZL201480010615.0 |
LactoSporin®, LactoSporin® + Sabilize® |
75 | Melanogenesis inhibition by 3,5-dimethoxy-4'-hydroxypterostilbenes and cosmeceutical applications thereof | DPR Korea 1011504 |
PteroWhite® |
76 | Use of piperine as a bioavailability enhancer | Europe EP0810868 |
BioPerine® |
77 | Bioprotectant composition, method of use and extraction process of curcuminoids | Europe EP0839037 |
Curcumin C3 Complex® |
78 | Forskolin for promoting lean body mass | Europe EP0977564 |
ForsLean® |
79 | Neuroprotective compositions and their use | Europe EP3638278 |
Sabroxy® |
80 | Enzyme composition for therapeutic management of muscle soreness | Europe EP3534934 |
DigeZyme® |
81 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Europe EP3478304 |
LactoSpore® |
82 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Europe EP3356545 |
LactoSpore® |
83 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3291805 |
Cyperus |
84 | Coconut water and its method of preparation | Europe EP1341547 |
Cococin™ |
85 | Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells | Europe EP1328263 |
Curcumin C3 Reduct® |
86 | Bioavailable composition of natural and synthetic HCA | Europe EP1254209 |
Garcitrin® |
87 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Europe EP3240553 |
LactoSpore® |
88 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Europe EP1171144 |
Curcumin C3 Reduct® |
89 | Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Europe EP1968620 |
SelenoForce® |
90 | Process for preparing water soluble diterpenes and their applications | Europe EP1718568 |
Ocufors® |
91 | Compositions and methods for the management of hyperproliferative dermatological conditions | Europe EP1791423 |
Boswellin® |
92 | Hepatoprotectant activity of garcinol | Europe EP2658374 |
Livinol™ |
93 | Protective compositions for dermal papilla cells | Europe EP2461786 |
Saberry® + Cococin™ |
94 | Method for the treatment of hypercholesterolemia | Europe EP2937084 |
Calebin |
95 | Calebin A for use in the treatment of inflammation and obesity | Europe EP2663185 |
Calebin |
96 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Europe EP2695603 |
Saberry® + Cococin™ + Se Peptide |
97 | Composition and method for the protection of articular cartilage | Europe EP2893926 |
Calebin |
98 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Europe EP2989197 |
LactoSporin® |
99 | Calebin A for inducing lipolysis | Europe EP3085370 |
Calebin |
100 | Synthesis of Calebin A and its biologically active analogs | Europe EP2963007 |
Calebin |
101 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP2744571 |
Cyperus |
102 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3108935 |
Cyperus |
103 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Europe EP3185877 |
LactoSpore® |
104 | Process and composition for achieving mammalian energy balance | Europe EP3194575 |
Forskolin |
105 | Skin care compositions and their applications | India IN356811 |
Ethyl Asccorbic acid + Sabiwhite® |
106 | A method for solubilizing forskolin and a composition thereof | India IN235492 |
Ocufors® |
107 | A Process of preparing a synergistic composition for treating hyperproliferative dermatological condition | India IN238950 |
Boswellin® |
108 | A process for obtaining high purity fatty alcohols | India IN229695 |
Policosanol |
109 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Japan JP7039626 |
LactoSporin® |
110 | Compositions for the management of hyperglycemia and related conditions | Japan JP7012857 |
Nigellin® |
111 | Compositions and methods for reducing flatulence | Japan JP6987888 |
LactoSpore® |
112 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Japan JP6979518 |
Oletrip |
113 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Japan JP6938479 |
LactoSpore® |
114 | Use of Piperine as a bioavailability enhancer | Japan JP3953513 |
BioPerine® |
115 | Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Japan JP6920462 |
Artocarpus hirsutus |
116 | Skin care applications of extracellular metabolites from Bacillus coagulans | Japan JP6918988 |
LactoSporin® |
117 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Japan JP6908633 |
LactoSpore® |
118 | Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Japan JP6896885 |
Artocarpus hirsutus |
119 | Enzyme composition for therapeutic management of muscle soreness | Japan JP6857240 |
DigeZyme® |
120 | Composition containing Oroxylin A and method of extraction thereof | Japan JP6851476 |
Sabroxy® |
121 | Composition for management of Helicobacter pylori infection | Japan JP6839329 |
LactoSpore® + Saberry® |
122 | Neuroprotective compositions and their use | Japan JP6796217 |
Sabroxy® |
123 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6759243 |
Cyperus |
124 | Process of obtaining compositions of stable Lutein and Lutein derivatives | Japan JP4227409 |
Xenogard® |
125 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Japan JP4098985 |
Cosmoperine® |
126 | Bio-available compositions of natural and synthetic HCA | Japan JP4205943 |
GarCitrin® |
127 | Compositions and methods for the management of hyper-proliferative dermatological conditions | Japan JP4820819 |
Boswellin® |
128 | Process for preparing water soluble diterpenes and their applications | Japan JP5021305 |
Ocufors® |
129 | Hepatoprotectant activity of garcinol | Japan JP5980228 |
Livinol™ |
130 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Japan JP6064274 |
Saberry® + Cococin™ + Se Peptide |
131 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Japan JP6126307 |
LactoSporin®, LactoSporin® + Sabilize® |
132 | Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6135761 |
Cyperus |
133 | Composition and method for the protection of articular cartilage | Japan JP6142446 |
Calebin |
134 | Calebin A for hepatic steatosis | Japan JP6336943 |
Calebin |
135 | Oleanoyl peptide composition and a method of treating skin aging | Japan JP6176893 |
Olepent® |
136 | Method for the treatment of hypercholesterolemia | Japan JP6263707 |
Calebin |
137 | Anti-obesity potential of Calebin A | Japan JP6374716 |
Calebin |
138 | Process and compositions for achieving mammalian energy balance | Japan JP6472453 |
Forskolin |
139 | Synthesis of Calebin A and its biologically active analogs | Japan JP6490927 |
Calebin |
140 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Japan JP6584526 |
Zingiber cassumnar |
141 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Japan JP6629875 |
LactoSpore® |
142 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Japan JP6630723 |
LactoSpore® |
143 | Process and compositions for achieving mammalian energy balance | Japan JP7012857 |
Nigellin® |
144 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Mexico MX389328 |
Forskolin |
145 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Mexico MX376004 |
LactoSpore® |
146 | Process for preparing water soluble diterpenes and their applications | Mexico MX260326 |
Ocufors® |
147 | Composition for down-regulating pro-inflammatory markers | Mexico MX328842 |
Boswellin® PS |
148 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Mexico MX355546 |
Saberry® + Cococin™ +Se Peptide |
149 | Process and compositions for achieving mammalian energy balance | Malaysia MY-188869-A |
Forskolin |
150 | Oleanoyl peptide composition and collagen enhancement | Mexico MY-188723-A |
Olepent® |
151 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Malaysia MY-185340-A |
LactoSpore® |
152 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Malaysia MY-182658-A |
LactoSpore® |
153 | Calebin A for hepatic steatosis | Malaysia MY-182000-A |
Calebin |
154 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Malaysia MY-181102-A |
LactoSporin® |
155 | Compositions and method for the protection of articular cartilage | Malaysia MY-175867-A |
Calebin |
156 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Malaysia MY-168089-A |
Saberry® + Cococin™ +Se Peptide |
157 | Method for the treatment of hypercholesterolemia | Malaysia MY-170067-A |
Calebin |
158 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Malaysia MY-174855-A |
LactoSpore® |
159 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Newzealand NZ732234 |
LactoSpore® |
160 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Newzealand NZ748360 |
LactoSpore® |
161 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Newzealand NZ748553 |
LactoSpore® |
162 | Composition containing Oroxylin A and method of extraction thereof | Newzealand NZ753943 |
Sabroxy® |
163 | Enzyme composition for therapeutic management of muscle soreness | Newzealand NZ752952 |
DigeZyme® |
164 | Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives | Newzealand NZ552997 |
Forskolin |
165 | Compositions and methods for the management of hyperproliferative dermatological conditions | Newzealand NZ552027 |
Boswellin® |
166 | Commercial process for making forskolin and its derivatives | Newzealand NZ568652 |
Ocufors® |
167 | Process for preparing water soluble diterpenes and their applications | Newzealand NZ545765 |
Ocufors® |
168 | Bioavailable composition of natural and synthetic HCA | Newzealand NZ518116 |
GarCitrin® |
169 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Newzealand NZ514884 |
Curcumin C3 Reduct® |
170 | Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Newzealand NZ568233 |
SelenoForce® |
171 | Protective compositions for dermal papilla cells | Newzealand NZ598630 |
Saberry®+ Cococin™ |
172 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Newzealand NZ600307 |
Saberry®+ Cococin™ + Se dipeptide |
173 | Method for the treatment of hypercholesterolemia | Newzealand NZ624269 |
Calebin |
174 | Hepatoprotectant activity of garcinol | Newzealand NZ609878 |
Livinol™ |
175 | Anti-obesity potential of Calebin A | Newzealand NZ614076 |
Calebin |
176 | Synthesis of Calebin A and its biologically active analogs | Newzealand NZ627247 |
Calebin |
177 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Newzealand NZ622927 |
Cyperus |
178 | Anti-obesity potential of calebin A | Newzealand NZ715053 |
Calebin |
179 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Newzealand NZ711345 |
LactoSporin®, LactoSporin® + Sabilize® |
180 | Composition and method for the protection of articular cartilage | Newzealand NZ622909 |
Calebin |
181 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Newzealand NZ735027 |
Zingiber cassumnar |
182 | Method to solubilize curcuminoids in water | Newzealand NZ734491 |
UC3 clear® |
183 | Process and compositions for achieving mammalian energy balance | Newzealand NZ720422 |
Forskolin |
184 | Anti-pollution compositions containing Bacillus coagulans | Russia RU2745755 |
LactoSpore® |
185 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Russia RU2733372 |
Oletrip |
186 | Compositions and methods for the management of hyperproliferative dermatological conditions | Russia RU2366412 |
Boswellin® |
187 | Anti-obesity potential of Calebin A | Russia RU2543334 |
Calebin |
188 | Hepatoprotectant activity of garcinol | Russia RU2585245 |
Livinol™ |
189 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Russia RU2606752 |
Saberry® + Cococin™ + Se Peptide |
190 | Calebin A for hepatic steatosis | Russia RU2643297 |
Calebin |
191 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Russia RU2617965 |
LactoSporin®, LactoSporin® + Sabilize® |
192 | Calebin A for osteoporosis | Russia RU2653103 |
Calebin |
193 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Russia RU2694053 |
Zingiber cassumnar |
194 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Russia RU2691404 |
Cyperus |
195 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Singapore SG11201707112P |
Zingiber cassumnar |
196 | Process and compositions for achieving mammalian energy balance | Singapore SG11201801873T |
Forskolin |
197 | Process for preparing water soluble diterpenes and their applications | Singapore SG121197 |
Ocufors® |
198 | Compositions and methods for the management of hyperproliferative dermatological conditions | Singapore SG136165 |
Boswellin® |
199 | Calebin A for hepatic steatosis | Singapore SG10201503805X |
Calebin |
200 | Composition and methods for the protection of articular cartilage | Singapore SG11201605336Y |
Calebin |
201 | Anti-obesity potential of calebin A | Singapore SG192695 |
Calebin |
202 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Singapore SG11201505628P |
LactoSporin®, LactoSporin® + Sabilize® |
203 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Singapore SG11201700006U |
LactoSpore® |
204 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Singapore SG11201707106U |
Cyperus |
205 | Liver protectant composition and therapeutic applications | South Africa ZA2020/06540 |
LivLonga® |
206 | Modulation of immune function by Bacillus coagulans | South Africa ZA2020/07348 |
Immunospore |
207 | Skin care compositions and their applications | South Africa ZA2020/06708 |
Ethyl Ascorbic Acid + SabiWhite® |
208 | Compositions for the management of hyperglycemia and related conditions | South Africa ZA2020/04532 |
Nigellin® |
209 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | South Africa ZA2019/00501 |
LactoSpore® |
210 | Enzyme composition for maintenance of metabolic health | South Africa 2019/07676 |
DigeZyme® |
211 | Composition and methods for the management of hyperproliferative dermatological Conditions | South Africa ZA2007/0694 |
Boswellin® |
212 | Process for preparing water soluble diterpenes and their applications | South Africa ZA2006/01898 |
Ocufors® |
213 | Anti-obesity potential of Calebin A | South Africa ZA2013/05918 |
Calebin |
214 | Method to solubilize curcuminoids in water | South Africa ZA2017/06503 |
UC3 Clear® |
215 | Enzyme composition for therapeutic management of muscle soreness | South Africa ZA2019/02715 |
DigeZyme® |
216 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Great Britain GB2380675 |
Cosmoperine® |
217 | Process for preparing water soluble diterpenes and their application | Uzbekistan 4028 |
Ocufors® |
218 | Process and composition for achieving mammalian energy balance | Eurasia EA38685 |
Forskolin |
219 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Eurasia EA037312 |
LactoSpore® |
220 | Process for preparing water soluble diterpenes and their applications | Eurasia EA012836 |
Ocufors® |
221 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Eurasia EA038255 |
LactoSpore® |
222 | Protective compositions for dermal papilla cells | Eurasia EA20368 |
Saberry® + Cococin™ |
223 | Use of a composition for down-regulating/inhibiting PGE2 | Eurasia EA023717 |
Boswellin® PS |
224 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Eurasia EA025578 |
Cyperus |
225 | Method for the treatment of hypercholesterolemia | Eurasia EA027148 |
Calebin |
226 | Use of calebin A to protect mammalian articular cartilage from pathological damage | Eurasia EA027614 |
Calebin |
227 | Synthesis of calebin A and its biologically active analogs | Eurasia EA027726 |
Calebin |
228 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Eurasia EA034017 |
LactoSpore® |
229 | Oleanoyl peptide composition and collagen enhancement | Eurasia EA03512 |
Olepent® |
230 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Philippines PH1-2017-50132 |
LactoSpore® |
231 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Philippines PH1-2017-500059 |
LactoSpore® |
232 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Philippines PH1-2015-500349 |
Cyperus |
233 | Process for preparing water soluble diterpenes and their applications | Philippines PH1-2006-500481 |
Ocufors® |
234 | Method for the treatment of hypercholesterolemia | Philippines PH1-2014-000244 |
Calebin |
235 | Calebin A for hepatic steatosis | Philippines PH1-2015-000188 |
Calebin |
236 | Composition and method for the protection of articular cartilage | Philippines PH1-2016-501138 |
Calebin |
237 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Philippines PH1-2015-502025 |
LactoSporin®, LactoSporin® + Sabilize® |
238 | Anti-pollution compositions containing Bacillus coagulans | Republic of Korea KR10-2376076 |
LactoSpore® |
239 | Skin care applications of extracellular metabolites from Bacillus coagulans | Republic of Korea KR10-2296051 |
LactoSporin® |
240 | Anti-obesity potential of garcinol | Republic of Korea KR10-2289324 |
Garcinol |
241 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Republic of Korea KR10-2288904 |
LactoSporin® |
242 | Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans | Republic of Korea KR10-2288897 |
LactoSporin® |
243 | Process and compositions for achieving mammalian energy balance | Republic of Korea KR10-2169620 |
Forskolin |
244 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Republic of Korea KR10-2157043 |
LactoSpore® |
245 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1600212 |
Cyperus |
246 | Synthesis of Calebin A and its biologically active analogs | Republic of Korea KR10-1629561 |
Calebin |
247 | Method for the treatment of hypercholesterolemia | Republic of Korea KR10-1647549 |
Calebin |
248 | Composition and method for the protection of articular cartilage | Republic of Korea KR10-1685263 |
Calebin |
249 | Composition and method for the protection of articular cartilage | Republic of Korea KR10-1685333 |
Calebin |
240 | Anti-obesity potential of Calebin A | Republic of Korea KR10-1702702 |
Calebin |
251 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1717889 |
Cyperus |
252 | Calebin A for hepatic steatosis | Republic of Korea KR10-1763474 |
Calebin |
253 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Republic of Korea KR 10-1770902 |
LactoSporin®, LactoSporin® + Sabilize® |
254 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Republic of Korea KR10-2089566 |
LactoSpore® |
255 | Oleanoyl peptide composition and collagen enhancement | Indonesia IDP000074771 |
Olepent® |
256 | Novel pcr primers and methods thereof for the identification of Bacillus coagulans | Indonesia IDP000074645 |
LactoSpore® |
257 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia PID201708495 |
Cyperus |
258 | Process and compositions for achieving mammalian energy balance | Indonesia IDP000071226 |
ForsLean® |
259 | Calebin A for hepatic steatosis | Indonesia IDP000067993 |
Calebin |
260 | Synergistic selenopeptide formulations for the protection of dermal papilla cell | Indonesia IDP000051688 |
Saberry® + Cococin™ + Se-dipeptide |
261 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Indonesia IDP00201506134 |
LactoSporin®, LactoSporin® + Sabilize® |
262 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia IDP000062703 |
Cyperus |
263 | Calebin A and its effect on hypercholesterolemia | Indonesia IDP000064827 |
Calebin |
264 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Indonesia IDP000066793 |
LactoSpore® |
265 | Compositions and methods for the management of hyperproliferative dermatological conditions | United Arab Emirates AE3178 |
Boswellin® |
- Active
- Expired
370 Great Patents
- Australia30
- Canada23
- China7
- DPR Korea1
- Eurasia12
- Europe29
- Germany1
- Great Britain1
- Hong Kong10
- India4
- Indonesia10
- Japan34
- Malaysia10
- Mexico6
- New Zealand25
- Philippines8
- Republic of Korea17
- Russia11
- Singapore10
- South Africa11
- Taiwan2
- UAE1
- USA102
- Uzbekistan1
- Vietnam1